An Open Label Comparing the Short Term Efficacy of Lacrisert

An Open Label Comparing the Short Term Efficacy of Lacrisert

To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.

Inclusion Criteria:

-Has Dry Eye disease indicated by a staining score of ≥ 4 and Speed score of >6

Exclusion Criteria:

• Concurrent involvement in any other clinical trial
• Anticipated contact lens wear during the study and 14hours prior to Day -History of corneal transplant
• Active ocular infection, uveitis or non-KCS inflammation
• History of recurrent herpes keratitis or active disease within the last six months
• Topical ophthalmic medications during the study
• Temporary collagen punctal plugs within one week prior to study.